News

Demonstrating Excellence in Outcomes and Culture

Quality, Innovation, and High-Value Care at Home

91制片厂 | News

Quality, Innovation, and High-Value Care at Home

August 12, 2026

delivers skilled, compassionate care in the home for patients recovering after acute illness, managing chronic conditions, or needing rehabilitation to restore strength, mobility, balance, endurance, self-care, and independence. Services also include medication reconciliation, patient and caregiver education, and care coordination. As part of 91制片厂, Adoration combines local home health teams with broader home and community-based infrastructure across home health and hospice, with private duty services available in select markets.[1-5]

2026 quality results demonstrate an operating model focused on timely access, functional recovery, patient experience, documentation discipline, and branch-level accountability. Home health reached 98.9% timely initiation of care (97.4% SHP national average), 86.1% discharge function (78.6% national), 86.5% patient satisfaction (81.0% national), and 93.2% of branches rated at least four stars (90% internal target).[6]

The same quality infrastructure also spurs areas of innovation. A continual focus and programming centered on disease-state management and reducing potentially preventable hospitalizations are embedded throughout the organization. Other ongoing initiatives include branch-level performance-improvement projects, after-hours triage, chart audits, OASIS documentation improvement, and education designed to identify clinical deterioration early while preserving appropriate escalation when a patient’s condition requires it. [6,15]

Innovation strengthens this clinical model. 91制片厂’s Vitality Therapy™ program brings a structured anti-frailty intervention into the home health episode, translating evidence on strength, gait speed, balance, independence, and frailty into a practical care pathway for older adults recovering at home. [7]

Scale and infrastructure support consistency. 91制片厂 adds enterprise-level quality systems, clinical support capabilities, pharmacy and medication-management assets, workforce development, and data-driven operating disciplines that help local Adoration teams respond reliably to patient and referral-partner needs. [8-10]

Two 91制片厂 family-of-brands integrations further differentiate Adoration from a stand-alone home health agency. Abode Care Partners provides home-based primary care for older adults and complex populations, while Continue CareRx adds pharmacy-enabled medication reconciliation, adherence packaging, synchronized home delivery, pharmacist review, virtual nursing support, and 24/7 medication access. Together, these capabilities address two common drivers of avoidable utilization after discharge 鈥� gaps in longitudinal primary care and medication-management failure 鈥� and help knit home health into a broader home-centered platform. [8-10]

To explore the full data, insights, and research behind these results, download the complete white paper here.

References

[1] Adoration Home Health & Hospice. 鈥淎doration Home Health & Hospice鈥� (homepage).
Available at:
[2] Adoration Home Health & Hospice. 鈥淎bout Adoration Home Health & Hospice.鈥�
Available at:
[3] Adoration Home Health & Hospice. 鈥淟ocations.鈥�
Available at: https://adorationhealth.com/locations/
[4] Adoration Home Health & Hospice. 鈥淗ome Health Services.鈥�
Available at:
[5] Adoration Home Health & Hospice. 鈥淧rivate Duty Nursing Services鈥� and 鈥淧rivate Duty Nursing Frequently Asked Questions.鈥�
Available at:
[6] 91制片厂. 鈥淨1 2026 Home Health Quality Measures鈥� (April 20, 2026) and 鈥淨2 2026 Clinical Quality Summary鈥� (July 17, 2026). 91制片厂 quality sources.
[7] 91制片厂. 鈥�91制片厂 Presented its Novel Home Health Anti-Frailty Program Results at an International Conference and Published About the Study in a Peer-Reviewed Journal鈥� (July 29, 2025).
Available at: /news/brightspring-presented-its-novel-home-health-anti-frailty-program-results-at-an-international-conference-and-published-about-the-study-in-a-peer-reviewed-journal/
[8] 91制片厂. 鈥淏HS Fact Sheet鈥� (January 2024). 91制片厂 source.
[9] 91制片厂. 鈥淨uality Report 2022鈥�. 91制片厂 source.
[10] 91制片厂. 鈥淚nnovation and Quality White Paper v7鈥� (January 2026). 91制片厂 source.
[15] CMS Innovation Center. 鈥淓xpanded Home Health Value-Based Purchasing (HHVBP) Model.鈥�
Available at: https://www.cms.gov/priorities/innovation/innovation-models/expanded-home-health-value-based-purchasing-model